HyperArc Registry Study

Launched by VARIAN, A SIEMENS HEALTHINEERS COMPANY · Feb 25, 2022

Keywords

ClinConnect Summary

The HyperArc Registry Study is a clinical trial focused on understanding the effectiveness of a treatment called HyperArc for patients with brain metastases and other central nervous system conditions. By collecting data from patients receiving this treatment, researchers aim to see how well it works compared to other available options.

If you or a loved one is between the ages of 65 and 74 and has already started or is scheduled to receive the HyperArc treatment, you may be eligible to participate in this study. There are no specific exclusions, so as long as you meet the inclusion criteria, you could take part. Participants will be asked to sign a consent form, which means you agree to be part of the study and understand what it involves. If you join, you will help researchers gather important information that could improve future treatments for similar conditions.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Received or scheduled to receive treatment using the HyperArc treatment method
• • Age of legal adult according to local law
• • Signed informed consent form, or, informed consent waived by the local ethics board/institutional review board
• Exclusion Criteria:
• • None, apart from not meeting Inclusion Criteria